|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
18
|
|
pubmed:dateCreated |
1999-6-16
|
|
pubmed:abstractText |
Leishmaniasis in a patient with Wegenerís disease raises the problem of amphotericin toxicity further compromising the pre-existing renal disorder.
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0755-4982
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
959-61
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:10366930-Acute Kidney Injury,
pubmed-meshheading:10366930-Aged,
pubmed-meshheading:10366930-Amphotericin B,
pubmed-meshheading:10366930-Anemia,
pubmed-meshheading:10366930-Anti-Bacterial Agents,
pubmed-meshheading:10366930-Female,
pubmed-meshheading:10366930-Follow-Up Studies,
pubmed-meshheading:10366930-Humans,
pubmed-meshheading:10366930-Leishmaniasis, Visceral,
pubmed-meshheading:10366930-Liposomes,
pubmed-meshheading:10366930-Male,
pubmed-meshheading:10366930-Treatment Outcome,
pubmed-meshheading:10366930-Wegener Granulomatosis
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
[Visceral leishmaniasis associated with Wegener disease. Use of lipid complex amphotericin B and liposomal amphotericin B].
|
|
pubmed:affiliation |
Service de Médecine interne II, Hôpital de l'Archet I, Nice.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|
